Gewicht

Diabetes Medications: SGLT2 Inhibitors and GLP-1 Agonists Reduce Alzheimer’s Risk by 43% and 33%

by

Recent clinical research indicates that patients with Type 2 diabetes treated with SGLT2 inhibitors may experience a significantly lower incidence of Alzheimer’s disease compared to those using other glucose-lowering medications. According to a large-scale study published in The BMJ, the use of sodium-glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of dementia, suggesting … Read more

Real-World Study Reveals: Significant Weight Loss from GLP-1 & GLP-1/GIP Therapies Dramatically Reduces Risk of Complications-Including Sleep Apnea, Diabetes & More

by

Here is the verified, original article based on the provided context and strict adherence to the guidelines: New research confirms what many patients and physicians have long suspected: GLP-1 receptor agonists—widely prescribed for type 2 diabetes and obesity—are delivering more than just weight loss. A growing body of real-world evidence now links significant weight reduction … Read more

Understanding ADF: Benefits and Effects Every Other Day

by

Intermittent fasting, specifically alternate-day fasting (ADF), involves cycling between days of normal eating and days of little to no calorie intake. Recent research has explored its effects on various health markers,including aging and metabolic health. A 2019 study published in the journal Cell Metabolism investigated these effects in individuals with a normal Body Mass Index … Read more